These results were further corroborated by associating heightened PTP1b expression in the three types of cancers with lower overall patient survival; the study also utilized PTP1b inhibitor to markedly reduce tumor growth and increase survival rates in mice inoculated with GBM cells [31]. Here, PTPN1 is linked to glioblastoma.